China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Latest News

Today: Your daily dose of hand-picked AI stories

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's solved yet....

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI...

McKinsey: Scaling AI Beats Fragmented Business Pilots

McKinsey's latest State of AI numbers say what a...

Kawasaki and Dexterity Scale Physical AI for Warehouses

The warehouse floor has always been one of automation's...

Best Voice AI for Healthcare Front-Desk Automation in 2026

The healthcare front desk is one of the most strained operational environments in modern medicine, and voice AI for healthcare front-desk automation is the...

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI research labs. So when it joins a $310M Series B in Palo Alto startup Odyssey,...

Business

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's solved yet....

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI...

McKinsey: Scaling AI Beats Fragmented Business Pilots

McKinsey's latest State of AI numbers say what a...

Kawasaki and Dexterity Scale Physical AI for Warehouses

The warehouse floor has always been one of automation's...

Technology

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's solved yet....

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI...

McKinsey: Scaling AI Beats Fragmented Business Pilots

McKinsey's latest State of AI numbers say what a...

Kawasaki and Dexterity Scale Physical AI for Warehouses

The warehouse floor has always been one of automation's...

Join or social media

For even more Ai exclusive content!

Industry

China’s AI Companion Rules: What Beijing Is Really Going After

0
Starting July 15, China's biggest AI apps are pulling the plug on a feature millions of people had grown attached to. ByteDance's Doubao and...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

0
Idiopathic pulmonary fibrosis gives patients a median survival of two to four years after diagnosis. That grim math is why the latest news out...

Takeda’s $600M Bet on AI Drug Discovery

0
Takeda just handed a Hong Kong AI company up to $600 million to help find its next drugs. The target: Insilico Medicine, whose Pharma.AI...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

0
Drug discovery has a bottleneck problem, and it's not the science. It's the plumbing. Anthropic just addressed that with Claude Science, a new AI...

Proception Raises $11M for Dexterous Robotic Hand

0
Robot hands are the unglamorous problem nobody's solved yet. Even Elon Musk has called them one of the toughest engineering challenges left in robotics....

Startups

Funding

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling the plug on a feature millions of people had grown attached to. ByteDance's Doubao and...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of two to four years after diagnosis. That grim math is why the latest news out...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up to $600 million to help find its next drugs. The target: Insilico Medicine, whose Pharma.AI...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not the science. It's the plumbing. Anthropic just addressed that with Claude Science, a new AI...

Enterprise AI
Enterprise AI

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's...

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing...

McKinsey: Scaling AI Beats Fragmented Business Pilots

McKinsey's latest State of AI numbers say...

Kawasaki and Dexterity Scale Physical AI for Warehouses

The warehouse floor has always been one...

Did Alibaba Illegally Extract Anthropic’s AI?

Anthropic is accusing Alibaba of running the...

Boston Dynamics Invests $100M in New Massachusetts AI Hub

Boston Dynamics is planting its biggest flag...

ROI & Cost Analysis

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Robotics

Generative AI
Latest

China’s AI Companion Rules: What Beijing Is Really Going After

Starting July 15, China's biggest AI apps are pulling the plug on a feature millions of people had grown attached to. ByteDance's Doubao and...

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's solved yet....

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI...

McKinsey: Scaling AI Beats Fragmented Business Pilots

McKinsey's latest State of AI numbers say what a...

Kawasaki and Dexterity Scale Physical AI for Warehouses

The warehouse floor has always been one of automation's...

Did Alibaba Illegally Extract Anthropic’s AI?

Anthropic is accusing Alibaba of running the largest known...

Boston Dynamics Invests $100M in New Massachusetts AI Hub

Boston Dynamics is planting its biggest flag yet in...

Tools

Insilico Medicine’s AI Drug for IPF Moves Into Phase III

Idiopathic pulmonary fibrosis gives patients a median survival of...

Takeda’s $600M Bet on AI Drug Discovery

Takeda just handed a Hong Kong AI company up...

NVIDIA BioNeMo Speeds Up Anthropic’s Claude Science

Drug discovery has a bottleneck problem, and it's not...

Proception Raises $11M for Dexterous Robotic Hand

Robot hands are the unglamorous problem nobody's solved yet....

Odyssey Closes $310M Series B, Amazon Backs AI World Models

Amazon doesn't usually make headlines for backing niche AI...